Corona virus is quickly spreading around the world. The goal of viral management is to
disrupt the virus's life cycle, minimize lung damage, and alleviate severe symptoms …

Mesenchymal stem cell-derived exosomes (MSC-Exos) are nano-sized extracellular
vesicles which contain various MSC-sourced anti-fibrotic, immunoregulatory and angio …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition characterized by the abnormal
regulation of extracellular matrix (ECM) and epithelial‐mesenchymal transition (EMT). In this …

Pulmonary fibrosis (PF) is a chronic, progressive, irreversible and life‑threatening lung
disease. However, the pathogenesis and molecular mechanisms of this condition remain …

Abstract Introduction In Pakistan, chronic respiratory conditions contribute a large burden of
morbidity and mortality. A major reason for this is the lack of availability of local evidence …

CCN4 (cellular communication network factor 4), a highly conserved, secreted cysteine-rich
matricellular protein is emerging as a key player in the development and progression of …

Disruption of the epithelial‑mesenchymal transition (EMT) of activated lung cells is an
important strategy to inhibit the progression of idiopathic pulmonary fibrosis (IPF). The …

Pulmonary fibrosis (PF) is a progressive and irreversible pulmonary disease with a high
mortality rate and limited treatment options. The cAMP‑dependent protein kinase A, cGMP …

Idiopathic pulmonary fibrosis (IPF) is a fatal variation of the interstitial pulmonary illness
characterised by extracellular matrix deposition that leads to secretion of inflammatory …

Idiopathic pulmonary fibrosis (IPF) is a devastating progressive fibrotic disease affecting the
lungs and causing chronic respiratory failure. In IPF, adult alveolar type II stem cells (ATII) …